The global Europe Digital Biomarkers Market experienced robust growth, with its size reaching USD 1.86 Billion in 2022, and is projected to continue expanding at a remarkable revenue CAGR of 36.6% during the forecast period. This surge in market revenue can be attributed to the increasing utilization of Europe Digital Biomarkers in therapeutics, particularly in treating gastrointestinal disease, neurodegenerative diseases, cardiovascular diseases, and other chronic conditions.

https://www.reportsanddata.com..../report-detail/digit